发明名称 CANCER TREATMENT BY ULTRAPHERESIS REMOVING COMPOUNDS OF LESS THAN 120,000 DALTONS
摘要 Apparatus for treating a patient, comprising a sterile device for removing soluble receptors for tumor necrosis factor-1 (TNF-1), tumor necrosis factor-2 (TNF-2), interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6) or interferon-gamma (IFN-³) from blood or plasma of a patient, and having inlet and outlet means for connection to a pump and tubing to circulate the blood or plasma through the device. Preferably the device comprises antibodies or antibody fragments that selectively bind to the soluble receptors, or cytokines selected from TNF-1, TNF-2, IL-1, IL-2, IL-6 and IFN-³ or epitopes thereof that selectively bind to the respective soluble receptors, immobilized on a column or a filter.
申请公布号 EP1079875(B1) 申请公布日期 2006.09.20
申请号 EP19990928331 申请日期 1999.05.21
申请人 BIOPHERESIS TECHNOLOGIES, INC. 发明人 LENTZ, M. RIGDON
分类号 A61M1/34;A61M1/36;A61K31/00;A61K31/282;A61K31/337;A61K31/445;A61K31/555;A61K31/704;A61K33/24;A61K35/14;A61K38/00;A61K38/17;A61K38/19;A61K38/22;A61K39/00;A61K41/00;A61K45/00;A61P35/00 主分类号 A61M1/34
代理机构 代理人
主权项
地址
您可能感兴趣的专利